Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19

During the outbreak of coronavirus disease 2019 (COVID-19) clinicians are increasingly involved in the observation of possible neurological complications due to the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. Among neurologic emergencies, new onset seizures and status epilepticus in non-epileptic patients are up to now, infrequently reported [2].

Source: Seizure: European Journal of Epilepsy - July 14, 2020 Category: Neurology Authors: Giulia Monti, Giada Giovannini, Andrea Marudi, Roberta Bedin, Alessandra Melegari, Anna Maria Simone, Mario Santangelo, Alessandro Pignatti, Elisabetta Bertellini, Tommaso Trenti, Stefano Meletti Tags: Clinical letter Source Type: research